Growth Metrics

IDEAYA Biosciences (IDYA) Accumulated Depreciation & Amortization (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Accumulated Depreciation & Amortization for 7 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 12.5% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, up 12.5% year-over-year, with the annual reading at $2.7 million for FY2025, 12.5% up from the prior year.
  • Accumulated Depreciation & Amortization hit $2.7 million in Q4 2025 for IDEAYA Biosciences, up from $700000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.7 million in Q4 2025 to a low of $400000.0 in Q1 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $1.2 million across 5 years, with a median of $950000.0 in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 200.0% in 2023 and later crashed 61.11% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $1.7 million in 2021, then grew by 23.53% to $2.1 million in 2022, then increased by 19.05% to $2.5 million in 2023, then fell by 4.0% to $2.4 million in 2024, then increased by 12.5% to $2.7 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for IDYA at $2.7 million in Q4 2025, $700000.0 in Q3 2025, and $1.3 million in Q2 2025.